Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The CDC estimates that 21% of people living with HIV also have hepatitis C virus.
According to the CDC, approximately 21%of people living with HIV also have HCV.
People treated with Biktarvy were more likely to achieve an undetectable HBV viral load than those on a dolutegravir-based regimen.
The burden of viral and nonviral liver disease remains high even in the setting of hepatitis C microelimination.
People who are living with all three viruses have a greater likelihood of progressing to end-stage liver disease.
Cutting the duration of treatment also cut the likelihood of a cure.
People with both HIV and hepatitis C are at greater risk for myocardial infarction as they age, and traditional risk factors also matter.
Once-daily pill suppressed HBV viral load in nearly two thirds of people with HIV/HBV coinfection.
Held in person and virtually, AIDS 2022 is the world’s largest HIV-related gathering. From cure news to advocacy, here’s what to expect.
Suppression of hepatitis B virus with antiviral treatment lowered the risk of hepatocellular carcinoma by 58%.
Increased HCV testing and treatment for both HIV-positive and HIV-negative gay and bi men could help eliminate hep C.
Hepatitis C commonly spreads through condomless sex and injection drug use among men who have sex with men.
The Centers for Disease Control and Prevention has learned difficult lessons from such outbreaks over the past five years.
A recent study also found that having a higher body mass index was associated with a higher risk of fatty liver disease.
Coinfection with all three viruses ramped up mortality risk nine times compared with having none of the viruses.
A new study’s findings have led researchers to challenge physicians’ biases against certain groups.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.